Skip to main content

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. BOOT Boot Barn Holdings, Inc. 13G/A 15.2% 2y
BlackRock Inc. PPBI Pacific Premier Bancorp Inc 13G/A 14.7% 2y
BlackRock Inc. KTB Kontoor Brands, Inc. 13G/A 14.7% 2y
BlackRock Inc. LUMN Lumen Technologies, Inc. 13G/A 15.1% 2y
Christopher D. Maggiore ZIVO Zivo Bioscience, Inc. 13D 12.8% 2y
Halis Family Foundation SFES Safeguard Scientifics Inc 13G 5% 2y
GSK plc HLN Haleon plc 13D/A 4.2% 2y
Dechomai Asset Trust LEGH Legacy Housing Corp 13G/A 2% 2y
Daniel Wiegand LILMF Lilium N.V. 13D/A 4.4% 2y
RA CAPITAL MANAGEMENT, L.P. VXRT Vaxart, Inc. 13G 9.1% 2y
Karpus Management, Inc. EIM Eaton Vance Municipal Bond Fund 13D 15.29% 2y
RTW INVESTMENTS, LP CUTR Cutera, Inc. 13G 9.11% 2y
Cannae Holdings, Inc. PSFE Paysafe Ltd 13D/A 4% 2y
Cooperatieve Gilde Healthcare IV U.A. CVRX CVRx, Inc. 13D/A 6.6% 2y
Saba Capital Management, L.P. FMN Federated Hermes Premier Municipal Income Fund 13D/A 13.9% 2y
Pfizer Inc HLN Haleon plc 13D/A 32% 2y
Yaron Eitan MRAI Marpai, Inc. 13D/A 7.7% 2y
Camel Bay, LLC BFAC Battery Future Acquisition Corp. 13D 52.2% 2y
Damien Lamendola MRAI Marpai, Inc. 13D/A 34.3% 2y
10,000 Days Capital Management LLC DALN DallasNews Corporation Series A Common Stock 13D/A 3.75% 2y
Deep Track Capital, LP DYN Dyne Therapeutics, Inc. 13G 5.55% 2y
Commodore Capital LP ACET Adicet Bio, Inc. 13G 9.8% 2y
PERCEPTIVE ADVISORS LLC FUSN Fusion Pharmaceuticals Inc. Common Shares 13G 6.5% 2y
Century City International Holdings Limited AMTD Amtd Idea Group 13D/A 4% 2y
Emil Jesse Eisenhardt LEVI Levi Strauss & Co 13G/A 5.1% 2y
BlackRock Inc. XNCR Xencor Inc 13G/A 18.6% 2y
MILLENNIUM MANAGEMENT LLC NXTC NextCure, Inc. 13G/A 4.1% 2y
BlackRock Inc. ASIX AdvanSix Inc. 13G/A 18.2% 2y
BlackRock Inc. JBGS JBG SMITH Properties 13G/A 19% 2y
BlackRock Inc. COLL Collegium Pharmaceutical, Inc 13G/A 17.7% 2y
BlackRock Inc. NJR New Jersey Resources Corp 13G/A 17.6% 2y
BlackRock Inc. SUPN Supernus Pharmaceuticals, Inc. 13G/A 19% 2y
BlackRock Inc. GPI Group 1 Automotive Inc 13G/A 17.9% 2y
BlackRock Inc. HIBB Hibbett, Inc. Common Stock 13G/A 17.5% 2y
BlackRock Inc. REX REX AMERICAN RESOURCES Corp 13G/A 17.8% 2y
BlackRock Inc. LXP LXP Industrial Trust 13G/A 19.3% 2y
Eveline Muller CTLP Cantaloupe, Inc. 13G/A 5% 2y
BlackRock Inc. PCRX Pacira BioSciences, Inc. 13G/A 17.5% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares 13G/A 0% 2y
BlackRock Inc. OMCL Omnicell, Inc. 13G/A 17.3% 2y
BlackRock Inc. SLG Sl Green Realty Corp 13G/A 19.3% 2y
BlackRock Inc. AVA Avista Corp 13G/A 19.4% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC APCA AP Acquisition Corp 13G/A 0% 2y
BlackRock Inc. BHE Benchmark Electronics Inc 13G/A 18.2% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC BIOS BioPlus Acquisition Corp. Class A Ordinary Shares 13G/A 0% 2y
BlackRock Inc. HAYN Haynes International, Inc. 13G/A 17.5% 2y
BlackRock Inc. AIR Aar Corp 13G/A 17.6% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC ZPTA Zapata Quantum, Inc. 13G/A 0% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G/A 0% 2y
BlackRock Inc. DEA Easterly Government Properties, Inc. 13G/A 19.3% 2y